BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 7515593)

  • 1. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of natural antibody responses to malaria parasite surface proteins in the intermediate rainfall zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Indian J Med Res; 1995 Feb; 101():66-74. PubMed ID: 7729852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
    Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
    BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.
    Mendis C; Del Giudice G; Gamage-Mendis AC; Tougne C; Pessi A; Weerasinghe S; Carter R; Mendis KN
    Parasite Immunol; 1992 Jan; 14(1):75-86. PubMed ID: 1557232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.
    Chauhan VS; Chatterjee S; Johar PK
    Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
    Zhou Z; Xiao L; Branch OH; Kariuki S; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 2002 Jan; 66(1):7-12. PubMed ID: 12135271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil.
    Kremsner PG; Neifer S; Zotter GM; Bienzle U; Rocha RM; Maracic M; Clavijo P; Nussenzweig RS; Cochrane AH
    Trans R Soc Trop Med Hyg; 1992; 86(1):23-7. PubMed ID: 1373529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
    Riley EM; Morris-Jones S; Blackman MJ; Greenwood BM; Holder AA
    Parasite Immunol; 1993 Sep; 15(9):513-24. PubMed ID: 7877849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern immunological approaches to assess malaria transmission and immunity and to diagnose plasmodial infection.
    Daniel-Ribeiro CT; Oliveira-Ferreira J; Ferreira-Da-Cruz MF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():117-24. PubMed ID: 1342707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia.
    Kerkhof K; Sluydts V; Heng S; Kim S; Pareyn M; Willen L; Canier L; Sovannaroth S; Ménard D; Sochantha T; Coosemans M; Durnez L
    Malar J; 2016 Oct; 15(1):510. PubMed ID: 27756395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
    Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.
    Cook J; Speybroeck N; Sochanta T; Somony H; Sokny M; Claes F; Lemmens K; Theisen M; Soares IS; D'Alessandro U; Coosemans M; Erhart A
    Malar J; 2012 Mar; 11():86. PubMed ID: 22443375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.